A stroke therapy using stem cells extracted from patients’ bone marrow has shown promising results in the first trial of its kind in humans.
The therapy was found to be safe, and all the patients showed improvements in clinical measures of disability.
The findings are published in the journal Stem Cells Translational Medicine. It is the first UK human trial of a stem cell treatment for acute stroke to be published.
The therapy uses a type of cell called CD34+ cells, a set of stem cells in the bone marrow that give rise to blood cells and blood vessel lining cells. Previous research has shown that treatment using these cells can significantly improve recovery from stroke in animals. Rather than developing into brain cells themselves, the cells are thought to release chemicals that trigger the growth of new brain tissue and new blood vessels in the area damaged by stroke.
The Latest on: Stroke therapy
via Google News
The Latest on: Stroke therapy
- The healing power of music for stroke survivorson May 14, 2022 at 10:00 pm
Julie Stillman was 55 years old when a blood vessel in her brain suddenly burst. The hemorrhagic stroke left her unable to compose a simple sentence – a hard blow ...
- Stroke month: experts call attention to stroke preventionon May 13, 2022 at 5:50 pm
Every 40 seconds—that’s how often someone has a stroke in the United States. It’s the fifth leading cause of death among Americans, with someone dying of a stroke every 3.5 minutes.
- What Golden Hour for Stroke? Introducing the 'Platinum Half-Hour'on May 13, 2022 at 11:51 am
platinum half hour treatment is likely to be associated with maximal intervention benefit," the authors argued in their paper in Stroke. Given the precious minutes spent waiting for EMS to arrive on ...
- Stroke awareness and rapid response can save lives | Guestviewon May 12, 2022 at 11:07 am
Luckily, he recognized the signs of a stroke and called 911.” Now, more than ever, minutes matter when it comes to preventing death and disability caused by strokes. Today, new technologies, ...
- Uncertain Results for Tenecteplase in 'Wake-up' Strokeon May 12, 2022 at 10:10 am
The TWIST trial aimed to show benefit of the new bolus thrombolytic in patients with 'wake-up' stroke selected by noncontrast CT, but turned out to be underpowered to achieve a definitive result.
- We Must Improve Stroke Outcomes in People With Disabilities and Dementia, Scientists Sayon May 11, 2022 at 4:01 pm
American Heart Association and the American Stroke Association issued a joint statement on the need to improve stroke outcomes in people with disabilities to provide better care to this historically ...
- Spotting the early signs of a stroke is critical to survival and recoveryon May 11, 2022 at 3:17 pm
IN THESE AREAS THE STROKES ARE THE FTHIF LEADING CSEAU OF DEATH IN OUR STATE SPOTTING THE EARLY SYMPTOMS THAT’S CRITICAL TO SURVIVAL AND RECOVERY IN A STORY. YOU’LL SEE ONLY ON SENEV GENEVIEVE GLASS - ...
- First Commercial Vivistim Patient Set to Begin Paired VNS Therapy for Improved Upper Limb Function Post Strokeon May 11, 2022 at 6:31 am
MicroTransponder®, Inc. reached a milestone Tuesday with the first commercial use of its Vivistim® Paired VNS™ System. A medical device company that develops solutions to restore independence and ...
- Second Trial Shows Thrombectomy Benefit in Basilar Artery Strokeon May 11, 2022 at 6:16 am
The BAOCHE trial has shown a large benefit of endovascular thrombectomy for patients with a stroke caused by a basilar artery occlusion.
- Bringing Advanced Stroke Care Closer to Homeon May 10, 2022 at 2:58 pm
It’s hard for Dr. Mohamad Ezzeldin to forget 2018, what he considers to be a game-changing year for stroke treatment. This was when the treatment guidelines for mechanical thrombectomy—a ...
via Bing News